JP2004502696A5 - - Google Patents

Download PDF

Info

Publication number
JP2004502696A5
JP2004502696A5 JP2002507824A JP2002507824A JP2004502696A5 JP 2004502696 A5 JP2004502696 A5 JP 2004502696A5 JP 2002507824 A JP2002507824 A JP 2002507824A JP 2002507824 A JP2002507824 A JP 2002507824A JP 2004502696 A5 JP2004502696 A5 JP 2004502696A5
Authority
JP
Japan
Prior art keywords
compound
compound according
ring
alkaryl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002507824A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004502696A (ja
Filing date
Publication date
Priority claimed from GBGB0016052.3A external-priority patent/GB0016052D0/en
Application filed filed Critical
Publication of JP2004502696A publication Critical patent/JP2004502696A/ja
Publication of JP2004502696A5 publication Critical patent/JP2004502696A5/ja
Pending legal-status Critical Current

Links

JP2002507824A 2000-06-30 2001-06-26 癌治療用のルテニウム(ii)化合物 Pending JP2004502696A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0016052.3 2000-06-30
GBGB0016052.3A GB0016052D0 (en) 2000-06-30 2000-06-30 Ruthenium (II) compounds
PCT/GB2001/002824 WO2002002572A1 (en) 2000-06-30 2001-06-26 Ruthenium (ii) compounds for use in the therapy of cancer

Publications (2)

Publication Number Publication Date
JP2004502696A JP2004502696A (ja) 2004-01-29
JP2004502696A5 true JP2004502696A5 (https=) 2008-07-24

Family

ID=9894730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002507824A Pending JP2004502696A (ja) 2000-06-30 2001-06-26 癌治療用のルテニウム(ii)化合物

Country Status (14)

Country Link
US (1) US6936634B2 (https=)
EP (1) EP1294732B1 (https=)
JP (1) JP2004502696A (https=)
AT (1) ATE273985T1 (https=)
AU (1) AU2001267687A1 (https=)
BR (1) BR0112122A (https=)
CA (1) CA2414446A1 (https=)
DE (1) DE60105028T2 (https=)
DK (1) DK1294732T3 (https=)
ES (1) ES2227225T3 (https=)
GB (1) GB0016052D0 (https=)
MX (1) MXPA02012911A (https=)
PT (1) PT1294732E (https=)
WO (1) WO2002002572A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003512471A (ja) * 1999-10-27 2003-04-02 ユニバーシティ コート, エディンバラ大学 窒素および配位子を含む癌治療用の半サンドイッチ状ルテニウム(ii)化合物
AU2002346686A1 (en) * 2001-12-07 2003-06-23 Intermune, Inc. Compositions and method for treating hepatitis virus infection
GB0215526D0 (en) * 2002-07-05 2002-08-14 Univ Edinburgh Anticancer compounds
US7241913B2 (en) * 2003-04-30 2007-07-10 The University Court Of The University Of Edinburgh Ruthenium compounds
GB0418643D0 (en) * 2004-08-20 2004-09-22 Univ Edinburgh Ruthenium (II) compounds
GB0604602D0 (en) * 2006-03-07 2006-04-19 Univ Edinburgh Ruthenium (II) compounds
GB0610062D0 (en) * 2006-05-19 2006-06-28 Univ Edinburgh Ruthenium (ll) compounds
CN101851256B (zh) * 2010-04-30 2013-01-09 广东药学院 一种以柔性碳链联接的钌(ⅱ)卟啉配合物及其制备方法和应用
CN101863925B (zh) * 2010-05-21 2012-08-29 广东药学院 一种芳基钌(ⅱ)配合物及其制备方法和应用
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980472A (en) * 1983-06-23 1990-12-25 American Cyanamid Company Method of making (3-amino-1H-pyrazol-4-yl) (aryl)methanones
EP0191096B1 (de) * 1984-07-24 1989-09-13 ASTA Pharma AG Tumorhemmend wirkende rutheniumverbindungen
WO1986000804A1 (fr) 1984-07-24 1986-02-13 Byk Gulden Lomberg Chemische Fabrik Gesellschaft M Compositions de ruthenium a effet inhibiteur de tumeurs
US4980473A (en) * 1985-01-18 1990-12-25 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and chiral metal complexes as Z-specific anti-tumor agents
US4699978A (en) * 1985-01-18 1987-10-13 The Trustees Of Columbia University In The City Of New York Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents
US5225556A (en) * 1985-01-18 1993-07-06 The Trustees Of Columbia University In The City Of New York Chemical probes for left-handed DNA and for A-DNA; chiral metal complexes as Z-specific antitumor agents and as double strand cleavers
AU4017695A (en) 1994-10-28 1996-05-23 Procept, Inc. Ruthenium complexes and their use as immunosuppressive agents
JPH11209314A (ja) 1997-09-30 1999-08-03 Takasago Internatl Corp シクロオクタジエン類の製造方法
JP3488103B2 (ja) * 1998-11-12 2004-01-19 高砂香料工業株式会社 4−メチル−5−ヘキセン−1−アールを含有する香料組成物
GB0028025D0 (en) 2000-11-17 2001-01-03 Univ York Compounds

Similar Documents

Publication Publication Date Title
RU2223272C2 (ru) Производное 2-арил-8-оксодигидропурина, способ его получения, фармацевтическая композиция и средство, содержащие его, промежуточное соединение
JP2001247459A5 (https=)
CY1106784T1 (el) Υποκατεστημενα παραγωγα φαινυλ προπιονικου οξεος ως συναγωνιστες του ανθρωπινου υπεροξυσωματικου πολλαπλασιαστη - ενεργοποιημενου υποδοχεα αλφα (ppar)
JP2018524339A5 (https=)
SE0102299D0 (sv) Compounds
SE0102300D0 (sv) Compounds
JP2003514935A5 (https=)
JP2018519302A5 (https=)
JP2004502696A5 (https=)
JP2004531517A5 (https=)
CY1109449T1 (el) Ενωσεις ουριας δραστικες ως ανταγωνιστες βανιλλοειδων υποδοχεων για την αντιμετωπιση του πονου
MA28011A1 (fr) Derives de piperazine et leur utilisation en tant qu'agents therapeutiques
JP2001514167A5 (https=)
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
JP2007505902A5 (https=)
JP2004506736A5 (https=)
JP2004505947A5 (https=)
JP2005506352A5 (https=)
JP2017524025A5 (https=)
JP2002510633A5 (https=)
MY142551A (en) Substituted diaryl heterocycles, process for their preparation and their use as medicaments
PT1506185E (pt) Compostos novos e sua utilizacao
JP2019515908A5 (https=)
GB0428250D0 (en) Organic compounds
JP2004517098A5 (https=)